A detailed history of Ossiam transactions in Dexcom Inc stock. As of the latest transaction made, Ossiam holds 206,415 shares of DXCM stock, worth $16.6 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
206,415
Previous 205,453 0.47%
Holding current value
$16.6 Million
Previous $23.3 Million 40.62%
% of portfolio
0.27%
Previous 0.45%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$64.0 - $116.06 $61,568 - $111,649
962 Added 0.47%
206,415 $13.8 Million
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $21.2 Million - $27 Million
192,367 Added 1470.02%
205,453 $23.3 Million
Q1 2024

May 13, 2024

SELL
$114.22 - $140.1 $261,678 - $320,969
-2,291 Reduced 14.9%
13,086 $1.82 Million
Q4 2023

Feb 13, 2024

BUY
$75.49 - $124.16 $129,993 - $213,803
1,722 Added 12.61%
15,377 $1.91 Million
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $680,820 - $1.09 Million
7,911 Added 137.73%
13,655 $1.27 Million
Q2 2023

Aug 11, 2023

SELL
$112.47 - $130.98 $181,076 - $210,877
-1,610 Reduced 21.89%
5,744 $738,000
Q1 2023

May 12, 2023

SELL
$104.0 - $122.92 $913,224 - $1.08 Million
-8,781 Reduced 54.42%
7,354 $854,000
Q4 2022

Feb 13, 2023

BUY
$84.98 - $122.67 $347,228 - $501,229
4,086 Added 33.91%
16,135 $1.83 Million
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $1.61 Million - $1.99 Million
-21,123 Reduced 63.68%
12,049 $970,000
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $1.63 Million - $3.18 Million
23,908 Added 258.07%
33,172 $2.47 Million
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $619,987 - $858,017
-6,590 Reduced 41.57%
9,264 $4.74 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $955,323 - $1.2 Million
7,356 Added 86.56%
15,854 $8.51 Million
Q3 2021

Nov 12, 2021

BUY
$106.71 - $143.18 $79,392 - $106,525
744 Added 9.6%
8,498 $4.65 Million
Q2 2021

Aug 13, 2021

BUY
$80.99 - $107.93 $24,216 - $32,271
299 Added 4.01%
7,754 $4 Million
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $477,198 - $589,476
5,628 Added 308.05%
7,455 $2.68 Million
Q4 2020

Feb 12, 2021

SELL
$78.0 - $104.5 $25,350 - $33,962
-325 Reduced 15.1%
1,827 $675,000
Q3 2020

Nov 12, 2020

SELL
$95.51 - $112.95 $391,686 - $463,207
-4,101 Reduced 65.58%
2,152 $887,000
Q2 2020

Aug 13, 2020

BUY
$62.68 - $105.34 $391,938 - $658,691
6,253 New
6,253 $2.54 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Ossiam Portfolio

Follow Ossiam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.